News &amp; Updates

The use of statins for primary prevention in adults with type 1 diabetes mellitus (T1DM) appears to prevent all-cause mortality and major cardiovascular disease (CVD), with an acceptable safety profile, a study has shown.

Statins may protect adults with T1DM against all-cause death, CVD

Antidepressants and electroconvulsive therapy may reduce all-cause mortality in depression

In patients with depression, antidepressant use may lower all-cause mortality risk, while electroconvulsive therapy (ECT) is associated with reduced risks of all-cause, natural-cause, and suicide-related death, researchers from the University of Hong Kong (HKU) have reported.

Antidepressants and electroconvulsive therapy may reduce all-cause mortality in depression

19 Sep 2025

Clinical research in non-university public hospitals correlated with improved patient outcomes

More than 10 percent of full-time clinicians in Hong Kong’s non-university public hospitals engaged in original research as principal investigators (PIs), contributing to nearly one-third of the city’s peer-reviewed studies published in 2016–2021. Their clinical research activity is correlated with improved patient outcomes.

Clinical research in non-university public hospitals correlated with improved patient outcomes

Patient-reported outcomes prognostic of cancer survival

Patient-reported outcomes provide prognostic information for cancer survival, independent of other clinical factors, according to a study.

Patient-reported outcomes prognostic of cancer survival

Inclisiran-based strategy achieves LDL-C goals in patients at high CV risk

Treatment with inclisiran, on top of individually optimized lipid-lowering therapy (ioLLT), resulted in the achievement of guideline-recommended low-density lipoprotein cholesterol (LDL-C) targets among patients with hypercholesterolaemia at high or very high risk of cardiovascular (CV) events, according to the VICTORION-Difference trial presented at ESC 2025.

Inclisiran-based strategy achieves LDL-C goals in patients at high CV risk

Optimal glycaemic control associated with lower pancreatic cancer risk in T2D

In patients with type 2 diabetes (T2D), optimal glycaemic control is associated with lower risks of pancreatic cancer as well as pancreatic cancer–related mortality and all-cause mortality, a territory-wide population-based retrospective cohort study has shown.

Optimal glycaemic control associated with lower pancreatic cancer risk in T2D

19 Sep 2025

Nutrition content on TikTok: Reliable or not?

18 Sep 2025 by

A cross-sectional study shows that nutrition-related content from TikTok is heavily influenced by non-expert creators and diet culture, with misleading content often receiving higher engagement than credible information.

Nutrition content on TikTok: Reliable or not?

Vaginal estrogen tablets unlikely to increase risk of stroke recurrence

18 Sep 2025 by

Among women who have previously had an ischaemic stroke, the use of vaginal estradiol tablets does not raise the risk of having another stroke, according to new research.

Vaginal estrogen tablets unlikely to increase risk of stroke recurrence

LTSG delivers durable weight loss, improves metabolic syndrome

Simultaneous liver transplantation (LT) and sleeve gastrectomy (SG) is effective in sustaining weight loss, managing diabetes and hypertension, and preventing recurrence of steatosis and possibly fibrosis compared with LT alone, suggests a study.

LTSG delivers durable weight loss, improves metabolic syndrome

Patients with cirrhosis, AKI may require 48 h to respond to albumin therapy

18 Sep 2025 by

Many patients with cirrhosis and acute kidney injury (AKI) need 2 days to show response to albumin treatment, a study has found. Therefore, reducing the duration of albumin therapy may result in overtreatment with terlipressin.

Patients with cirrhosis, AKI may require 48 h to respond to albumin therapy